Officials at the American Society of Clinical Oncology are seeking approval of the model as a payment option in Medicare.
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.
AUSTIN, TEX. – “Timing of onset is a critical component to assist in identifying immune checkpoint inhibitor-associated versus non-immune...
In 2017, 21.7% of cancer deaths in the most rural counties were potentially preventable, compared with 3.2% in the most urban counties.
SAN ANTONIO – A majority of alerts triggered by red blood cell orders were overridden, but for sound clinical reasons, investigators found.
A reference guide for the latest drug approvals in hematology and oncology, including biosimilars.
The agency is collaborating with the Bill & Melinda Gates Foundation for the $200 million, 4-year project.
SAN ANTONIO – Favored more in Europe than North America, fibrinogen concentrate was noninferior to cryoprecipitate for control of bleeding after...
The observational trial showed that survival was significantly higher with transplant than with chemotherapy consolidation therapy in patients...
Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management....